DIAx Merger Approval: Fund Composition Set to Change

The Nuveen Dow 30 Dynamic Overwrite Fund (DIAX) has had its merger approved, and its composition is set to change. The fund's Board of Directors has been considering a corporate action, and investors should be aware of the potential implications. The change in composition is expected to affect the fund's performance and may impact investor returns. It is recommended that investors review the fund's prospectus and consult with a financial advisor before making any decisions.